164 related articles for article (PubMed ID: 18365374)
1. HLA matching by amino acid/positions in double and triple combinations.
Idica A; Sasaki N; Terasaki P
Clin Transpl; 2006; ():123-38. PubMed ID: 18365374
[TBL] [Abstract][Full Text] [Related]
2. Effect of amino acid mismatch in the UNOS dataset.
Sasaki N; El-Awar N; Idica A
Clin Transpl; 2011; ():299-309. PubMed ID: 22755423
[TBL] [Abstract][Full Text] [Related]
3. Effect of amino acid mismatch in the UNOS 2007 dataset.
Sasaki N; Idica A; Hall B; Terasaki P
Clin Transpl; 2007; ():241-54. PubMed ID: 18642455
[TBL] [Abstract][Full Text] [Related]
4. Overview and epitope matching.
Terasaki PI; Park MS; Takemoto S; Cecka JM; Clark B; Corcoran S; Cicciarelli J; Barbetti A; Yuge J; Carnahan E
Clin Transpl; 1989; ():499-516. PubMed ID: 2484860
[TBL] [Abstract][Full Text] [Related]
5. HLA compatibility and organ transplant survival. Collaborative Transplant Study.
Opelz G; Wujciak T; Döhler B; Scherer S; Mytilineos J
Rev Immunogenet; 1999; 1(3):334-42. PubMed ID: 11256424
[TBL] [Abstract][Full Text] [Related]
6. Using the mimetic epitope concept to find a possible way to widen the graft-survival difference between matched and mismatched renal transplants.
Sasaki N; Idica A; Hall B; Terasaki PI
Clin Transpl; 2008; ():241-52. PubMed ID: 19711515
[TBL] [Abstract][Full Text] [Related]
7. Refinement of permissible HLA mismatches.
Takemoto S; Terasaki PI
Clin Transpl; 1994; ():451-66. PubMed ID: 7547575
[TBL] [Abstract][Full Text] [Related]
8. HLAMatchmaker-based strategy to identify acceptable HLA class I mismatches for highly sensitized kidney transplant candidates.
Duquesnoy RJ; Witvliet M; Doxiadis II; de Fijter H; Claas FH
Transpl Int; 2004 Jan; 17(1):22-30. PubMed ID: 12955350
[TBL] [Abstract][Full Text] [Related]
9. Effect of mismatching serologically defined residues on kidney transplant survival.
Takemoto S; Terasaki PI; Park MS; Clark BD
Transplant Proc; 1992 Aug; 24(4):1266-8. PubMed ID: 1379751
[TBL] [Abstract][Full Text] [Related]
10. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
11. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. IV. An alternative strategy to increase the number of compatible donors for highly sensitized patients.
Duquesnoy RJ; Howe J; Takemoto S
Transplantation; 2003 Mar; 75(6):889-97. PubMed ID: 12660520
[TBL] [Abstract][Full Text] [Related]
12. HLA amino acid residue matching in 2575 kidney transplants.
Tan J; Qiu J; Tang X
Transplant Proc; 2007 Jun; 39(5):1429-31. PubMed ID: 17580154
[TBL] [Abstract][Full Text] [Related]
13. Renal after cardiothoracic transplant: the effect of repeat mismatches on outcome.
Caskey FJ; Johnson RJ; Fuggle SV; Start S; Pugh D; Dudley CR
Transplantation; 2009 Jun; 87(11):1727-32. PubMed ID: 19502967
[TBL] [Abstract][Full Text] [Related]
14. The role of DRB1 amino acid residue differences on donor-specific antibody production and acute rejection after cadaveric renal transplant.
Adorno D; Piazza A; Canossi A; Valeri M; Torlone N; Monaco PI; Papola F; Casciani CU
J Biol Regul Homeost Agents; 1999; 13(1):32-6. PubMed ID: 10432439
[TBL] [Abstract][Full Text] [Related]
15. Influence of mismatching of HLA cross-reactive groups on cadaveric kidney transplantation.
Hwang SH; Oh HB; Shin ES; Yew M; Kim SC; Han DJ
Transplant Proc; 2005 Dec; 37(10):4194-8. PubMed ID: 16387076
[TBL] [Abstract][Full Text] [Related]
16. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
17. Differential immunogenicity of HLA mismatches in clinical transplantation.
Claas FH; Dankers MK; Oudshoorn M; van Rood JJ; Mulder A; Roelen DL; Duquesnoy RJ; Doxiadis II
Transpl Immunol; 2005 Aug; 14(3-4):187-91. PubMed ID: 15982562
[TBL] [Abstract][Full Text] [Related]
18. Thirty year trend in kidney transplants: UCLA and UNOS Renal Transplant Registry.
Kaneku HK; Terasaki PI
Clin Transpl; 2006; ():1-27. PubMed ID: 18368703
[TBL] [Abstract][Full Text] [Related]
19. HLAmatchmaker: a molecularly based algorithm for histocompatibility determination. III. Effect of matching at the HLA-A,B amino acid triplet level on kidney transplant survival.
Duquesnoy RJ; Takemoto S; de Lange P; Doxiadis II; Schreuder GM; Persijn GG; Claas FH
Transplantation; 2003 Mar; 75(6):884-9. PubMed ID: 12660519
[TBL] [Abstract][Full Text] [Related]
20. B cell positive cross-match not due to anti-HLA Class I antibodies and first kidney graft outcome.
Praticò-Barbato L; Conca R; Magistroni P; Leonardi G; Oda A; Rosati F; Leone E; Tacconella M; Roggero S; Segoloni GP; Amoroso A
Transpl Immunol; 2008 Jul; 19(3-4):238-43. PubMed ID: 18675725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
